SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-15-208541
Filing Date
2015-06-01
Accepted
2015-06-01 13:28:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d931600d425.htm 425 17843
2 GRAPHIC g931600g23k38.jpg GRAPHIC 30570
3 GRAPHIC g931600g54p69.jpg GRAPHIC 26450
  Complete submission text file 0001193125-15-208541.txt   98389
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filed by) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23155 | Film No.: 15902518
SIC: 2836 Biological Products, (No Diagnostic Substances)